HilleVax Inc. (HLVX)
NASDAQ: HLVX
· Real-Time Price · USD
1.95
0.04 (2.09%)
At close: May 15, 2025, 3:59 PM
1.93
-1.03%
After-hours: May 15, 2025, 06:19 PM EDT
2.09% (1D)
| Bid | 1.75 |
| Market Cap | 97.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -106.5M |
| EPS (ttm) | -2.15 |
| PE Ratio (ttm) | -0.91 |
| Forward PE | -1.47 |
| Analyst | Hold |
| Ask | 1.98 |
| Volume | 608,131 |
| Avg. Volume (20D) | 224,522 |
| Open | 1.93 |
| Previous Close | 1.91 |
| Day's Range | 1.88 - 1.96 |
| 52-Week Range | 1.34 - 16.30 |
| Beta | 0.78 |
About HLVX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HLVX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HLVX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+7.49%
HilleVax shares are trading higher. The stock may ...
Unlock content with
Pro Subscription
10 months ago
-88.34%
HilleVax shares are trading lower after the company announced the NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants.
